Lazabemide

Lazabemide
Clinical data

Routes of administration	Oral
ATC code	none
Legal status
Legal status	Development terminated
Identifiers
IUPAC name N-(2-aminoethyl)-5-chloro-pyridine-2-carboxamide
CAS Number	103878-84-8
PubChem CID	71307
IUPHAR/BPS	6640
ChemSpider	64426
UNII	420HD787N9
KEGG	D04681
Chemical and physical data
Formula	C₈H₁₀ClN₃O
Molar mass	199.64 g/mol

Lazabemide (proposed trade names Pakio, Tempium) is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) that was under development as an antiparkinsonian agent but was never marketed.